Overview

Laryngeal Mask Airway (LMA) Insertion With Sevoflurane and Remifentanil

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine the most suitable effect-site concentration of remifentanil for the LMA insertion during inhaled induction with 8% sevoflurane in adults.
Phase:
N/A
Details
Lead Sponsor:
Gachon University Gil Medical Center
Treatments:
Remifentanil
Sevoflurane